Pg. Andreis et al., EFFECTS OF PITUITARY ADENYLATE-CYCLASE ACTIVATING PEPTIDE (PACAP) ON THE RAT ADRENAL SECRETORY ACTIVITY - PRELIMINARY IN-VITRO STUDIES, Life sciences, 56(2), 1994, pp. 135-142
Citations number
38
Categorie Soggetti
Biology,"Medicine, Research & Experimental","Pharmacology & Pharmacy
PACAP did not affect secretory activity of dispersed rat adrenocortica
l cells, but it markedly raised aldosterone (ALDO) and corticosterone
(B) production by adrenal slices, containing both medullary and cortic
al tissues. The secretagogue effects of PACAP were suppressed by PACAP
(6-38). a specific competitive antagonist. Isoprenaline (IF) enhanced
ALDO, but not B secretion of adrenal slices, and I-alprenoloI (AL) com
pletely blocked IP effect. AL and corticotropin-inhibiting peptide (CI
P) partially reversed ALDO response to a maximal effective concentrati
on of PACAP; AL did not affect B response to a maximal effective conce
ntration of PACAP, while CIP completely annulled it. Quarters of regen
erated adrenocortical autotransplants, that are completely deprived of
chromaffin cells, though displaying ALDO and B responses to IP and AC
TH, were insensitive to PACAP. The hypothesis is advanced that adrenal
medulla plays a pivotal role in the mechanism(s) underlying the adren
ocortical secretagogue action of PACAP. being mineralocorticoid and gl
ucocorticoid responses probably mediated by the release by chromaffin
cells of catecholamine and ACTH or exclusively ACTH, respectively.